Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I

Introduction The aim of this study was to compare mortality in community-based Australians with type 1 diabetes (T1D), without diabetes, or with type 2 diabetes (T2D).Research design and methods The longitudinal observational Fremantle Diabetes Study Phase I (FDS1) T1D cohort, matched people without...

Full description

Bibliographic Details
Main Authors: Timothy M E Davis, Wendy A Davis, Ruwani Rajapaksa
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/11/4/e003501.full
_version_ 1797729996358287360
author Timothy M E Davis
Wendy A Davis
Ruwani Rajapaksa
author_facet Timothy M E Davis
Wendy A Davis
Ruwani Rajapaksa
author_sort Timothy M E Davis
collection DOAJ
description Introduction The aim of this study was to compare mortality in community-based Australians with type 1 diabetes (T1D), without diabetes, or with type 2 diabetes (T2D).Research design and methods The longitudinal observational Fremantle Diabetes Study Phase I (FDS1) T1D cohort, matched people without diabetes from the FDS1 catchment area, and matched FDS1 participants with T2D were followed up from entry (1993–1996) to death/end-2017. Mortality rates (MRs) and mortality rate ratios (MRRs) were calculated. Cox regression models identified independent determinants of death.Results Of 121 participants with T1D and 484 age/sex/postcode-matched people without diabetes (pooled mean±SD age 43.1±15.3 years, 59.2% men), 55 (45.5%, MR 25.7 (95% CI 19.4 to 33.5)/1000 person-years) and 88 (18.2%, MR 8.5 (95% CI 6.8 to 10.4)/1000 person-years), respectively, died during 12 541 person-years of follow-up (MRR 3.04 (95% CI 2.13 to 4.31), p<0.001). Among participants with T1D, diagnosis at age 18–27 years and baseline HbA1c, urinary albumin:creatinine ratio, and retinopathy were independent predictors of death (p≤0.011). Twenty-five FDS1 participants died from cardiovascular disease (MR 11.7 (95% CI 7.6 to 17.3)/1000 person-years) vs 28 residents without diabetes (MR 2.7 (95% CI 1.8 to 3.9)/1000 person-years; MRR (95% CI) 4.34 (2.43, 7.73) (p<0.001). There were 93 FDS1 participants with T1D who were age/sex matched with an FDS1 participant with T2D and 53 (57.0%) and 37 (39.8%), respectively, died (p=0.027). In pooled Cox regression analysis, T1D was not a determinant of mortality (HR 1.18 (95% CI 0.71 to 1.97), p=0.523).Conclusions T1D substantially increases the risk of death, especially when diagnosed in late adolescence/young adulthood. Diabetes type does not influence mortality after adjustment for key confounding variables.
first_indexed 2024-03-12T11:37:40Z
format Article
id doaj.art-b1a28d303c0a41b481ce002e14bfad5f
institution Directory Open Access Journal
issn 2052-4897
language English
last_indexed 2024-03-12T11:37:40Z
publishDate 2023-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Diabetes Research & Care
spelling doaj.art-b1a28d303c0a41b481ce002e14bfad5f2023-09-01T03:30:07ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972023-08-0111410.1136/bmjdrc-2023-003501Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase ITimothy M E Davis0Wendy A Davis1Ruwani Rajapaksa2Department of General Medicine, Fremantle Hospital and Health Service, Palmyra DC, Western Australia, AustraliaMedical School, University of Western Australia, Perth, Western Australia, AustraliaDepartment of General Medicine, Fremantle Hospital and Health Service, Palmyra DC, Western Australia, AustraliaIntroduction The aim of this study was to compare mortality in community-based Australians with type 1 diabetes (T1D), without diabetes, or with type 2 diabetes (T2D).Research design and methods The longitudinal observational Fremantle Diabetes Study Phase I (FDS1) T1D cohort, matched people without diabetes from the FDS1 catchment area, and matched FDS1 participants with T2D were followed up from entry (1993–1996) to death/end-2017. Mortality rates (MRs) and mortality rate ratios (MRRs) were calculated. Cox regression models identified independent determinants of death.Results Of 121 participants with T1D and 484 age/sex/postcode-matched people without diabetes (pooled mean±SD age 43.1±15.3 years, 59.2% men), 55 (45.5%, MR 25.7 (95% CI 19.4 to 33.5)/1000 person-years) and 88 (18.2%, MR 8.5 (95% CI 6.8 to 10.4)/1000 person-years), respectively, died during 12 541 person-years of follow-up (MRR 3.04 (95% CI 2.13 to 4.31), p<0.001). Among participants with T1D, diagnosis at age 18–27 years and baseline HbA1c, urinary albumin:creatinine ratio, and retinopathy were independent predictors of death (p≤0.011). Twenty-five FDS1 participants died from cardiovascular disease (MR 11.7 (95% CI 7.6 to 17.3)/1000 person-years) vs 28 residents without diabetes (MR 2.7 (95% CI 1.8 to 3.9)/1000 person-years; MRR (95% CI) 4.34 (2.43, 7.73) (p<0.001). There were 93 FDS1 participants with T1D who were age/sex matched with an FDS1 participant with T2D and 53 (57.0%) and 37 (39.8%), respectively, died (p=0.027). In pooled Cox regression analysis, T1D was not a determinant of mortality (HR 1.18 (95% CI 0.71 to 1.97), p=0.523).Conclusions T1D substantially increases the risk of death, especially when diagnosed in late adolescence/young adulthood. Diabetes type does not influence mortality after adjustment for key confounding variables.https://drc.bmj.com/content/11/4/e003501.full
spellingShingle Timothy M E Davis
Wendy A Davis
Ruwani Rajapaksa
Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
BMJ Open Diabetes Research & Care
title Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
title_full Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
title_fullStr Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
title_full_unstemmed Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
title_short Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
title_sort comparative mortality and its determinants in community based people with type 1 diabetes the fremantle diabetes study phase i
url https://drc.bmj.com/content/11/4/e003501.full
work_keys_str_mv AT timothymedavis comparativemortalityanditsdeterminantsincommunitybasedpeoplewithtype1diabetesthefremantlediabetesstudyphasei
AT wendyadavis comparativemortalityanditsdeterminantsincommunitybasedpeoplewithtype1diabetesthefremantlediabetesstudyphasei
AT ruwanirajapaksa comparativemortalityanditsdeterminantsincommunitybasedpeoplewithtype1diabetesthefremantlediabetesstudyphasei